Liuzzo, G., & Patrono, C. (2020). The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: Comment on the ‘Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19’. Eur Heart J.
Styl ChicagoLiuzzo, Giovanna, a Carlo Patrono. "The Widely Promoted Antimalarial Drug Hydroxychloroquine Confers No Mortality Benefit in Hospitalized Patients With COVID-19: Comment On the ‘Effect of Hydroxychloroquine in Hospitalized Patients With COVID-19’." Eur Heart J 2020.
Citace podle MLALiuzzo, Giovanna, a Carlo Patrono. "The Widely Promoted Antimalarial Drug Hydroxychloroquine Confers No Mortality Benefit in Hospitalized Patients With COVID-19: Comment On the ‘Effect of Hydroxychloroquine in Hospitalized Patients With COVID-19’." Eur Heart J 2020.